Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

06. Februar 2018 08:37 ET | Quelle: Precipio, Inc.

Precipio Enters Japanese Liquid Biopsy Market with First Hospital Sale

NEW HAVEN, Conn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces its entry into the Japanese market with a first order of its ICE-COLD PCR™...
22. Januar 2018 08:27 ET | Quelle: Precipio, Inc.

Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania

NEW HAVEN, Conn., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO), today announced it is collaborating with the cytogenetics laboratory at the University of...
16. Januar 2018 08:27 ET | Quelle: Precipio, Inc.

Precipio Appoints New Sales VP to Manage Diagnostics Sales Expansion

NEW HAVEN, Conn., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO) has appointed Douglas Sites to the new position of Vice President of Sales where he will...
10. Januar 2018 08:27 ET | Quelle: Precipio, Inc.

Yale Study Demonstrates Four-Fold Superiority of Academic Level Diagnostic Accuracy

NEW HAVEN, Conn., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced preliminary data from an ongoing study on the impact of academic...
20. Dezember 2017 08:00 ET | Quelle: Precipio, Inc.

Precipio Launches Its Second New ICE-COLD PCR™ Targeted Enrichment Kit To Identify Mutations in Lung Cancer Using Liquid (Blood) Biopsies On Sanger Sequencing Platforms

NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), announced today the launch of the second new version of its ICE-COLD PCR™ (ICP) enrichment kit, used to identify...
14. Dezember 2017 08:00 ET | Quelle: Precipio, Inc.

Precipio Files a Patent Application for IV-Cell, its Novel Cytogenetics Media

NEW HAVEN, Conn., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), today announced the recent filing of a patent application for IV-Cell, a novel media (reagent) developed by Precipio...
20. November 2017 16:05 ET | Quelle: Precipio, Inc.

Precipio Announces Third Quarter 2017 Financial Results and Provides Corporate Update

NEW HAVEN, Conn., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), today announced financial results for the third quarter ended September 30, 2017 and provided an update on corporate...
16. November 2017 16:15 ET | Quelle: Precipio, Inc.

Precipio To Announce Third Quarter 2017 Financial Results and Provide a Company Update on Monday, November 20, 2017 at 4:05pm Eastern Time

NEW HAVEN, Conn., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), today announced it will issue financial results for the Third Quarter ended September 30, 2017 and provide an update...
14. November 2017 16:15 ET | Quelle: Precipio, Inc.

Precipio Appoints Samuel D. Riccitelli as Chairman of the Board of Directors and Elects David Cohen as Director

NEW HAVEN, Conn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), today announced that on November 8, 2017, Precipio’s Board of Directors (the “Board”) appointed Samuel D. Riccitelli...
13. November 2017 16:15 ET | Quelle: Precipio, Inc.

Precipio, Inc. Announces Closing of $2,748,000 Registered Direct Offering

NEW HAVEN, Conn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), announced today that it has completed a registered direct offering for the purchase and sale of 2,748 units, each...

Vorherige Seite